医療用食品の世界市場分析:製品タイプ別、用途タイプ別(糖尿病性ニューロパチー、[ADHD]、うつ病、アルツハイマー病、栄養欠乏)、セグメント予測、2014 – 2025

【英語タイトル】Medical Foods Market Analysis By Route Of Administration, By Product Type, By Application Type (Diabetic Neuropathy, [ADHD], Depression, Alzheimer's Disease, Nutritional Deficiency), And Segment Forecasts, 2014-2025

Grand View Researchが出版した調査資料(GVIEW707519)・商品コード:GVIEW707519
・発行会社(調査会社):Grand View Research
・発行日:2017年3月3日
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、医療用食品の世界市場について調査・分析し、医療用食品の世界市場動向、医療用食品の世界市場規模、市場予測、セグメント別医療用食品市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global medical foods market is expected to reach a value of USD 24.4 billion by 2025, according to a new report by Grand View Research, Inc. The medical foods market is anticipated to grow at a CAGR of 6.9% over the forecast period. The key factors supporting expansion include the growing awareness about medical foods, improvement in patient healthcare outcomes, rise in prevalence of several chronic diseases, increase in malnutrition, and continuous innovation.
The use of medical foods to assist the patients during the treatment of chronic diseases has been a prevalent practice. However, lack of awareness about the proper usage, quality concerns, and overlapping claims about benefits associated due to the usage of medical foods have restricted the growth of medical foods market.

The difference between functional foods, dietary supplements, and medical foods is still not clear for several healthcare practitioners. Therefore, errors in prescription or use of substitute products is a major trend observed in the market. Furthermore, the regulatory uncertainty pertaining to the classification of medical foods as a separate category has also affected the market growth.

The prevalence of chronic diseases such as diabetic neuropathy, Alzheimer’s, Attention Deficit Hyperactivity Disorder (ADHD), and several metabolic diseases is increasing rapidly The risk of neuropathy significantly increases with increase in age, changes in diet, and adoption of an unhealthy lifestyle. Some of the symptoms usually associated with neuropathy include numbness, tingling, and pain in the feet, arms, & legs. Furthermore, some of the key products used to treat this condition include Percura capsules, METANX, and Foltanx.

The growing number of patients with Alzheimer’s disease is also increasing rapidly. As per the estimates published by the Alzheimer’s Society, in the U.S., an estimated 5.4 million Americans across all ages are suffering from this disease. On further analysis of the data, it is observed that nearly 5.2 million people are aged 65 and above. Thus, rise in the geriatric population is also a major factor driving the medical foods market.

Further Key Findings from the Study Suggest:

In 2015, oral route held the highest share as majority of the products are administered through the oral feeding

In 2015, powders category accounted for nearly 79% of the market share

In 2015, diabetic neuropathy was the largest application with a share of 34.3% owing to growing awareness about nutritional requirements during the treatment of chronic diseases

Asia Pacific is expected to lead the growth with a CAGR of 7.8% from 2016 to 2025

Some of the key players are Danone; Nestlé; Abbott; Targeted Medical Pharma Inc.; Primus Pharmaceuticals Inc.; Mead Johnson & Company, LLC.; and Fresenius Kabi AG.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Primary Research
1.2.1 List of primary sources include:
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Medical Foods Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Growing prevalence of cancer
3.2.2 Increasing prevalence of chronic diseases
3.3 Market Restraint Analysis
3.3.1 Lack of awareness
3.3.2 Uncertainty in regulatory framework
3.4 Penetration & Growth Prospect Mapping
3.5 Medical Foods Market- SWOT Analysis, By Factor (Political & Legal, Economic & Technological)
3.6 Industry Analysis – Porter’s
Chapter 4 Medical Foods: Route of Administration Estimates & Trend Analysis
4.1 Medical Foods Market: Route of Administration Movement Analysis
4.2 Oral
4.2.1 Oral market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Enteral
4.3.1 Enteral market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Medical Foods: Product Estimates & Trend Analysis
5.1 Medical Foods Market: Product Movement Analysis
5.2 Pills
5.2.1 Pills market estimates and forecasts, 2014 – 2025 (USD Million)
5.3 Powder
5.3.1 Powder market estimates and forecasts, 2014 – 2025 (USD Million)
5.4 Others
5.4.1 Other products market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 6 Medical Foods: Application Estimates & Trend Analysis
6.1 Medical Foods Market: Application Movement Analysis
6.2 Diabetic Neuropathy
6.2.1 Diabetic neuropathy market estimates and forecasts, 2014 – 2025 (USD Million)
6.3 ADHD
6.3.1 ADHD market estimates and forecasts, 2014 – 2025 (USD Million)
6.4 Depression
6.4.1 Depression market estimates and forecasts, 2014 – 2025 (USD Million)
6.5 Alzheimer’s Disease
6.5.1 Alzheimer’s disease market estimates and forecasts, 2014 – 2025 (USD Million)
6.6 Nutritional Deficiency
6.6.1 Nutritional deficiency market estimates and forecasts, 2014 – 2025 (USD Million)
6.7 Others
6.7.1 Other application market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 7 Medical Foods: Regional Estimates & Trend Analysis, by Route of Administration, Product, and Application
7.1 Medical Foods Market Share by Region, 2014 & 2024
7.2 North America
7.2.1 North America medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.3 Europe
7.3.1 Europe medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.3.3 UK
7.3.3.1 UK medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Japan medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.4.3 China
7.4.3.1 China medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.6 MEA
7.6.1 MEA medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa medical foods market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Danone
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2 Nestle
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Abbott
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Targeted Medical Pharma
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Primus Pharmaceuticals Inc.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Fresenius Kabi AG
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 MEIJI HOLDING AND CO.
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Mead Johnson & Company, LLC;
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 VICTUS, INC.
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market summary (USD Million)
FIG. 5 Market trends & outlook
FIG. 6 Market segmentation & scope
FIG. 7 Market driver relevance analysis (Current & future impact)
FIG. 8 Market restraint relevance analysis (Current & future impact)
FIG. 9 Penetration & growth prospect mapping
FIG. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 11 Porter’s five forces analysis
FIG. 12 Medical foods market route of administration outlook key takeaways
FIG. 13 Medical foods market: Application movement analysis
FIG. 14 Global oral market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 15 Global enteral market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 16 Medical foods market product outlook key takeaways
FIG. 17 Medical foods market: Product movement analysis
FIG. 18 Global pills market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 19 Global powder market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 20 Global other products market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 21 Medical foods market product outlook key takeaways
FIG. 22 Medical foods market: application movement analysis
FIG. 23 Global diabetic neuropathy market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Global ADHD market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 Global powder market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 26 Global ADHD market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 27 Global Alzheimer's disease market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 28 Global nutritional deficiency market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 29 Global other application market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 30 Regional market place: Key takeaways
FIG. 31 Regional outlook, 2015 & 2024
FIG. 32 North America medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 33 U.S. medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 34 Canada medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 35 Europe medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 36 Germany medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 37 UK medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 38 Asia Pacific medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 39 Japan medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 40 China medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 41 Latin America medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 42 Brazil medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 43 Mexico medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 44 MEA medical foods market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 45 South Africa medical foods market estimates and forecasts, 2014 - 2025 (USD Million)

List of Tables

TABLE 1 Number of new cases and estimated death due to cancer, by region, 2012
TABLE 2 Estimated prevalence of diabetes in 2015 and 2040, by region
TABLE 3 North America medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 4 North America medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 5 North America medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 6 U.S. medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 7 U.S. medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 8 U.S. medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 9 Canada medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 10 Canada medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 11 Canada medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 12 Europe medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 13 Europe medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 14 Europe medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 15 Germany medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 16 Germany medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 17 Germany medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 18 UK medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 19 UK medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 20 UK medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 22 Asia Pacific medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 23 Asia Pacific medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 24 Japan medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 25 Japan medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 26 Japan medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 27 China medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 28 China medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 29 China medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 30 Latin America medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 31 Latin America medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 32 Latin America medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 33 Brazil medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 34 Brazil medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 35 Brazil medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 36 Mexico medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 37 Mexico medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 38 Mexico medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 39 MEA medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 40 MEA medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 41 MEA medical foods market, by application, 2014 - 2025 (USD Million)
TABLE 42 South Africa medical foods market, by route of administration, 2014 - 2025 (USD Million)
TABLE 43 South Africa medical foods market, by product, 2014 - 2025 (USD Million)
TABLE 44 South Africa medical foods market, by application, 2014 - 2025 (USD Million)

★調査レポート[医療用食品の世界市場分析:製品タイプ別、用途タイプ別(糖尿病性ニューロパチー、[ADHD]、うつ病、アルツハイマー病、栄養欠乏)、セグメント予測、2014 – 2025] (コード:GVIEW707519)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用食品の世界市場分析:製品タイプ別、用途タイプ別(糖尿病性ニューロパチー、[ADHD]、うつ病、アルツハイマー病、栄養欠乏)、セグメント予測、2014 – 2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆